Drugmaker Stada confirms takeover bid from two companies

(Reuters) - German generic drugmaker Stada said it has received two offers for the acquisition of the company, one of which is private equity group Cinven Partners LLP. Cinven is offering a price of 56 euros per Stada share. Stada did not mention the name of the other bidder.